SCHEMBL23764644

SCHEMBL23764644

CC(O)OC(C)OC(O)C(C)N1C(=O)C(=O)c2cc(F)ccc21

nearest known ligand 0.43

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
PARK7 Q99497 4/20 0.43
TRPA1 O75762 1/20 0.35
CHRM5 P08912 2/20 0.34
ALDH1A1 P00352 6/20 0.34
ALDH3A1 P30838 4/20 0.34
NSD2 O96028 1/20 0.34
ALOX15 P16050 1/20 0.33
CA1 P00915 1/20 0.32
CA2 P00918 1/20 0.32
IDO1 P14902 1/20 0.31
TDO2 P48775 1/20 0.31
IDO2 Q6ZQW0 1/20 0.31
PDE5A O76074 1/20 0.30
ACHE P22303 1/20 0.30
CASP3 P42574 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23764669 0.90 PARK7 (0.40) PARK7TRPA1CHRM5ALDH1A1ALDH3A1
SCHEMBL23764693 0.89 PARK7 (0.41) PARK7TRPA1CHRM5ALDH1A1ALDH3A1
SCHEMBL23764619 0.87 PARK7 (0.43) PARK7TRPA1CHRM5ALDH1A1ALDH3A1
SCHEMBL23764690 0.84 PARK7 (0.41) PARK7TRPA1CHRM5ALDH1A1ALDH3A1
SCHEMBL23764648 0.83 CHRM5 (0.46) CHRM5
SCHEMBL23764714 0.83 CHRM5 (0.46) CHRM5
SCHEMBL23764686 0.82 PARK7 (0.45) PARK7TRPA1CHRM5ALDH1A1ALDH3A1
SCHEMBL23764660 0.82 PARK7 (0.51) PARK7TRPA1CHRM5ALDH1A1ALDH3A1
SCHEMBL23764712 0.77 PARK7 (0.54) PARK7TRPA1CHRM5ALDH1A1ALDH3A1
SCHEMBL23764705 0.77 PARK7 (0.42) PARK7TRPA1CHRM5ALDH1A1ALDH3A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021162650-A1 5-FLUORO/5-TRIFLUOROMETHOXY-1H-INDOLE-2,3-DIONE 3-(4-PHENYLTHIOSEMICARBAZONE) DERIVATIVES AS INTERLEUKIN 1 (IL-1) ANTAGONISTS AND ANTI-PYRETIC AND/OR ANTI-INFLAMMATORY AGENTS FOR USE IN TREATING E.G. BEHÇET'S DISEASE ISTANBUL UNIVERSITESI (TR) 2021-08-19 WO disclosed